3 big yielders I’d buy and hold for the next 5 years

Royston Wild runs the rule over three London-quoted dividend heroes.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With data from the housing industry continuing to surpass expectations, I reckon Taylor Wimpey (LSE: TW) remains a great dividend stock to buy and hang onto well into the future.

Latest Bank of England data showed mortgage approval for property purchases galloping to 11-month highs in January, up 2.4% from December levels, to 69,928, again confounding predictions of a slump in homebuyer appetite.

And Taylor Wimpey itself lauded the strength of the domestic homes market this week. The builder commented that “UK housing market fundamentals remain good with strong customer confidence in our core geographies,” adding that “the market is underpinned by a competitive mortgage market and low interest rates.”

Despite fresh rhetoric from the government in the form of a recent white paper, hard action to address the country’s massive housing imbalance remains elusive, and this should continue to power shareholder returns at the likes of Taylor Wimpey.

With earnings therefore expected to keep rising at the firm, the City has chalked-in dividends of 13.8p and 14.9p per share in 2017 and 2018 respectively, yielding 7.5% and 8%. I reckon the Taylor Wimpey should be on the radar of all serious dividend searchers.

The perfect payout pill?

The exceptional progress of GlaxoSmithKline’s (LSE: GSK) R&D teams convinces me that the pharma ace should deliver increasingly-handsome dividends in the years to come.

The company has kept the dividend locked at 80p per share since 2014 as it has invested heavily in its product pipeline and tackled the problems of critical patent expirations. And the City expects GlaxoSmithKline to make good on its pledge to keep payouts around this level until the end of this year. This creates a bumper 4.8% yield.

And as the firm’s suite of new earnings drivers flies off the shelves — new product sales rocketed to £4.5bn during 2016 — the abacus bashers expect GlaxoSmithKline to get dividends moving higher again from 2018. An 80.3p per share reward is currently forecast, also yielding 4.8%.

And with it expecting test data on between 20 to 30 assets by the close of next year alone, I reckon the groundwork could be laid for spectacular earnings, and consequently dividend growth, further down the line.

Star in space

I also reckon Big Yellow Group (LSE: BYG) should keep churning out exceptional dividends as occupancy rates at its storage sites rise.

The business saw like-for-like revenues edge 5% higher during October-December, with demand for its lock-ups picking up following a difficult start to the quarter. While Big Yellow commented in January that “significant uncertainties remain around the UK’s economic outlook,” the company’s bias towards the South East and London should protect it from the worst of any bumpiness. Indeed, just under half of the firm’s facilities can be found within the M25.

The City certainly expects its rich record of profits growth to keep rolling and has consequently chalked-in dividends of 27.6p per share for the year to March 2017 and 30.1p for fiscal 2018. These figures yield 3.8% and 4.1% respectively, and I reckon the space star is in great shape to keep throwing out market-beating rewards.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Warren Buffett owns this FTSE 100 stock. But should I?

Warren Buffett rarely invests in FTSE 100 shares but he does have a position in Diageo. Is it time for…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

After returning 101% in 2024 is this FTSE bank the best share to buy for 2025?

FTSE 100 bank NatWest Group turned out to be the best share to buy at the start of this year.…

Read more »

Investing Articles

Could Helium One be a millionaire-maker penny stock?

Shares of Helium One Global (LON:HE1) have soared 272% so far this year. Should I buy this penny stock while…

Read more »

Investing Articles

Are these 2 unsung FTSE blue-chips the passive income stocks I never knew I wanted?

Harvey Jones says that the FTSE 100 contains fantastic passive income stocks with deceptively modest yields. Here are two he's…

Read more »

A mixed ethnicity couple shopping for food in a supermarket
Investing Articles

Shhhh… These FTSE 250 stocks have quietly more than doubled in 2024

Forget those US tech titans. Our writer takes a closer look at two supposedly 'boring' FTSE 250 stocks that have…

Read more »

Investing Articles

As the Diageo share price flies on a double upgrade is this my last chance to buy it on the cheap?

The Diageo share price has inflicted plenty of pain on Harvey Jones in 2024, but suddenly it's serving up a…

Read more »

Investing Articles

7%+ yields! 3 choices to consider for a Stocks and Shares ISA

Christopher Ruane highlights a trio of FTSE companies each yielding over 7% he thinks investors should consider for a Stocks…

Read more »

Passive income text with pin graph chart on business table
Dividend Shares

How investors might try to turn £10,000 into a chunky passive income

Our writer Ken Hall looks at how the magic of compounding returns might help investors to create a handy second…

Read more »